Definium Therapeutics Inc (DFTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 159,919 | 80,094 | 0 | 0 | 0 |
| Marketable Securities | 71 | N/A | 0 | 0 | 0 |
| TOTAL | $162,287 | $81,519 | $0 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 19 | N/A | N/A | N/A | N/A |
| Intangibles | 38,488 | 0 | 0 | 0 | 0 |
| TOTAL | $38,507 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $200,794 | $81,519 | $0 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,450 | 2,022 | 0 | 0 | 0 |
| Accrued Expenses | N/A | 986 | 0 | 0 | 0 |
| TOTAL | $6,450 | $3,008 | $0 | $0 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 2,643 | 0 | 0 | 0 |
| TOTAL | $6,750 | $2,643 | $N/A | $N/A | $N/A |
| Total Liabilities | $13,200 | $5,651 | $0 | $0 | $0 |
| Shareholders' Equity | |||||
| Common Shares | 216,687 | N/A | 0 | 0 | 0 |
| Retained earnings | -55,658 | -44,636 | 0 | 0 | 0 |
| Other shareholders' equity | 23,321 | 284 | 0 | 0 | 0 |
| TOTAL | $187,594 | $75,868 | $0 | $0 | $0 |
| Total Liabilities And Equity | $200,794 | $81,519 | $0 | $0 | $0 |